MBX MBX Biosciences, Inc.
Company Analysis
Latest News
MBX Biosciences PT Raised to $88 at Truist, Driven by Obesity Data
Truist Securities raised its price target for MBX Biosciences, Inc. to $88 from $70. The investment firm reiterated its Buy rating on the stock. This new...
MBX Biosciences Surges 10% on Earnings Anticipation — But Can a Cash-Burning Biotech With No Revenue Justify the Optimism?
Shares of MBX Biosciences jumped 10% to $70.88 on August 7 as investors piled in ahead of what turned out to be the company's Q2 2026 earnings release —...
🔴 MBX Biosciences is trading 4% down today as traders reposition ahead of Q2 earnings
MBX Biosciences is trading at $67.87 (4% down) as traders reposition ahead of its Q2 2026 earnings report scheduled for August 06, 2026. • Analysts expect the...
MBX Biosciences, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
MBX Biosciences is projected to report no revenue and a consensus loss of $0.63 per share for Q2 2026, with the current $69.52 share price trading below the...
🟢 MBX Biosciences is trading 10.1% up today ahead of earnings and amid sector strength
MBX Biosciences is trading 10.1% up now at $70.88 as traders position ahead of its upcoming earnings report, expected around August 5–6, 2026. • Investor...
🟢 MBX Biosciences is trading 4.1% up today ahead of earnings and broader market strength
MBX Biosciences is trading at $67.03, up 4.1% today, as investors position ahead of its upcoming earnings report and amid broader market strength. • The...
🟢 MBX Biosciences is trading 4% up today amid a sector-wide biotech and market rally
MBX Biosciences is trading at $66.54 (up 4%), moving in line with a strong rebound in growth stocks and biotech peers rather than any fresh company-specific...
🟢 MBX Biosciences is trading 4.13% up today amid broader risk-on sentiment and higher Nasdaq futures
MBX Biosciences is trading at $66.60 (+4.13%) in pre-market sessions, appearing to move in tandem with a broader market rebound rather than specific corporate...
🟢 MBX Biosciences is trading 4.1% up today on a modest intraday rebound
MBX Biosciences is trading at $62.53 (+4.11%) on a modest intraday rebound despite a lack of company-specific catalysts or regulatory updates. • No major...
🟢 MBX Biosciences is trading 5.3% up
MBX Biosciences is trading at $61.40, up 5.3% from a comparison close of $58.30 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 5.0% down
MBX Biosciences is trading at $57.26, down 5.0% from a comparison close of $60.28 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 4.2% down today following a downgrade to "Sell" by Wall Street Zen
MBX Biosciences is trading at $60.27 (down 4.2%) today. The decline follows a downgrade by Wall Street Zen from a "hold" to a "sell" rating issued on...
🟢 MBX Biosciences is trading 4.2% up today on company-specific rebound and pipeline optimism
MBX Biosciences is trading 4.2% up today at $60.77 as shares rebound from recent biotech sector volatility and risk-off pressure. • The move appears to be a...
🔴 MBX Biosciences is trading 4.2% down today on risk-off sentiment hitting the biotech sector
MBX Biosciences is trading 4.2% down at $58.15 as broader pressure on biotech and growth stocks weighs on the share price. • The move comes despite a lack of...
🟢 MBX Biosciences is trading 5.2% up
MBX Biosciences is trading at $59.55, up 5.2% from a comparison close of $56.59 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 10.5% down today amid broader biotech sector pressure
MBX Biosciences is trading at $53.99 (-10.48%) as the stock faces a sharp selloff driven by broader weakness in the biotechnology industry. • The move appears...
🔴 MBX Biosciences is trading 13.1% down
MBX Biosciences is trading at $52.19, down 13.1% from a comparison close of $60.04 during pre-market. This is a price-action follow-up, so a separate catalyst...
🔴 MBX Biosciences is trading 5.9% down today after announcing a major executive leadership transition
MBX Biosciences is trading 5.9% down at $56.52 following the announcement of a major executive leadership transition effective immediately. • The Board has...
MBX Biosciences Appoints New CEO and CFO in Major Leadership Transition
MBX Biosciences announced a significant leadership transition, with CEO Kent P. Hawryluk stepping down effective July 13, 2026. The company has appointed its...
🔴 MBX Biosciences is trading 10.0% down
MBX Biosciences is trading at $54.02, down 10.0% from a comparison close of $60.04 during after-hours. This is a price-action follow-up, so a separate catalyst...